Designed to stabilize and fuse the SI joint
SI-BONE, Inc. has developed a minimally invasive surgical (MIS), innovative, patented, sacroiliac implant system for sacroiliac (SI) joint conditions including disruptions and degenerative sacroiliitis. The iFuse Implant System® consists of titanium implants and associated surgical instruments.
The iFuse Implant™, available since 2009, is made of titanium and has a porous, titanium plasma spray (TPS) coating. TPS technology has been used for decades in other medical applications such as orthopedics and dentistry. More than thirty published, peer-reviewed articles demonstrate safety and effectiveness of the iFuse Implant.***
The iFuse-3D™ Implant is created with the latest proprietary 3D printing technology. The surface mimics native cancellous bone and uses self-harvesting technology. At the discretion of the surgeon, the implant may be packed with allograft or autograft prior to insertion.
Typically, patients receive three triangular-shaped titanium implants. Available implant lengths range from 30mm to 70mm in 5mm increments. These implants are delivered to the sacroiliac (SI) joint using a cannulated delivery system designed to protect soft tissue. The surgery is performed through a 2-3cm incision.
Potential iFuse benefits
With the iFuse Implant System, there is no need for:
Possible benefits versus traditional surgical SI joint fixation
Possible benefits of a minimally invasive surgical procedure
* SI-BONE Test Report 300191
The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months. There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For information about the risks, visit: www.si-bone.com/risks